FOLFOX: 124 Real Stories

124 stories match FOLFOX. 107 of them mention surgery.

Cancer Stories

A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Metastatic Colorectal Cancer With Severe Hypocalcemia After Denosumab

Patient Info: Anonymized, male, 70+ | Stage IV

Biomarkers: MLH1, PMS2, MSH2 and MSH6 retained; DPYD wild type

Metastatic Site: bone, liver

Bone imaging in November 2023 showed progression with more extensive skeletal involvement while he remained under care for metastatic colorectal cancer.

PubMed Central
OutcomeSetback / Progression
Alicia, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Alicia's Patient Story

Patient Info: Alicia Blakey, Under 40 | Stage III

Alicia was undergoing FOLFOX chemotherapy for Stage III colon cancer through October 2024 after colon surgery in May.

Fight Colorectal Cancer
OutcomeCare Ongoing
Amy, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Amy's Patient Story

Patient Info: Amy Nicole, Female, Under 40 | Stage IV

Metastatic Site: liver; lymph nodes near kidneys/retroperitoneal lymph…

As of June 2024, Amy was living with recurrent Stage IV colon cancer and was on an immunotherapy clinical trial that improved quality of life compared with chemotherapy, though she did not describe remission or NED.

The Patient Story
OutcomeLiving With Cancer
Jessica, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Jessica's Survivor Story

Patient Info: Jessica Dazzler, Female, Under 40 | Stage IV

Biomarkers: FoundationOne testing performed; exact mutation not stated

Metastatic Site: lungs, spine, rib

As of May 2024, Jessica said it took 3 years and 4 months to reach no evidence of disease after Stage IV colorectal cancer, though she remained anxious about future scans and possible circulating cancer.

The Patient Story
OutcomeCancer-Free / NED
Michael, who was diagnosed with Stage III Colorectal AdenocarcinomaColorectal Cancer

Stage III Colorectal Adenocarcinoma: Michael's Survivor Story

Patient Info: Michael Holtz, Male, 40s | Stage III

Michael reported that capecitabine with radiation, surgery, and FOLFOX worked for him; current surveillance findings and recurrence status were not provided.

Fight Colorectal Cancer
OutcomeSurvivorship / Completed Treatment
Justine, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IIIB to metastatic rectal cancer: setback and treatment journey

Patient Info: Justine, Female, Under 40 | Stage IV

Metastatic Site: Liver; lung

As of March 2024, Justine was living with metastatic rectal cancer involving liver and lung, described as treatable but not curable, after surgery, permanent ileostomy, IV chemotherapy, liver ablation, lung SBRT, and Y-90 liver radioembolization.

The Patient Story
OutcomeLiving With Cancer
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Colon cancer recurrence at a surgical drain site

Patient Info: Anonymized, Male

He recovered well after abdominal-wall excision and was followed every 3–6 months, with no clinical signs of further recurrence or metastasis.

PubMed Central
OutcomeSurvivorship / Surveillance
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Pembrolizumab led to complete response before surgery for metastatic dMMR colon cancer

Patient Info: Anonymized, male, 70+ | Stage IV

Biomarkers: dMMR/MSI-H; MLH1 loss; PMS2 loss; BRAF mutation; heterozygous MUTYH p. pathogenic variant

Metastatic Site: liver

The 2023 liver resection showed a pathological complete response with no residual tumor, and he entered follow-up without additional therapy.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Stage IV colon cancer treated with FOLFOX during hemodialysis

Patient Info: Anonymized, male, 70+ | Stage IV

Biomarkers: RAS mutation; BRAF wild type

Metastatic Site: lung

Cancer was controlled during chemotherapy for a period, but modified FOLFOX was ultimately stopped because the disease progressed.

PubMed Central
OutcomeSetback / Progression
Jelena, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Jelena's Survivor Story

Patient Info: Jelena, Female, Under 40 | Stage III

As of January 2024, Jelena was on annual follow-up after Stage III rectal cancer treatment, with her latest colonoscopy showing no polyps or suspicious findings.

The Patient Story
OutcomeCancer-Free / NED
Jason, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Jason's Patient Story

Patient Info: Jason Reese, Male, 40s | Stage IV

Metastatic Site: Liver

As of January 2024, Jason still had active Stage IV rectal cancer, but extensive liver metastases had decreased from innumerable lesions to very few visible on scans, and treatment planning continued.

The Patient Story
OutcomeResponding Well
A patient, who was diagnosed with Gastric AdenocarcinomaGastric Cancer

HER2-Positive Metastatic Stomach Cancer Presenting With Tumor Lysis Syndrome

Patient Info: Anonymized, Male | Stage Metastatic/Advanced

Biomarkers: HER2 positive

Metastatic Site: liver

His metastatic gastric cancer progressed despite FOLFOX6 and trastuzumab. He entered hospice about 1 year later and died a few months afterward.

PubMed Central
OutcomeIn Memory
Jim, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Jim's Patient Story

Patient Info: Jim Bromwich, Male, Under 40 | Stage IV

Metastatic Site: Lung

As of January 2024, he had completed focused radiation to an isolated lung nodule and was awaiting follow-up scans; another tiny lung nodule was being monitored but was not PET-avid.

The Patient Story
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Rectal signet ring cell cancer with an unusual metastasis into a lipoma

Patient Info: Anonymized, male, 40s | Stage IV

Metastatic Site: subcutaneous abdominal wall lipoma, peritoneum

Peritoneal carcinomatosis developed during adjuvant FOLFOX. Second-line chemotherapy was proposed, and he died 12 months later.

PubMed Central
OutcomeIn Memory
Jeff, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Jeff's Patient Story

Patient Info: Jeff Williams, Male, 50s | Stage IV

Metastatic Site: Liver; lungs

As of December 2023, Jeff was living with recurrent Stage IV colorectal cancer, had recently developed more lung tumors, continued chemotherapy locally every 2 weeks, and returned to UT MD Anderson every 3 months for scans.

MD Anderson
OutcomeLiving With Cancer
Barbara, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Barbara's Survivor Story

Patient Info: Barbara, Female, 40s | Stage III

As of November 2023, Barbara described herself as a colon cancer survivor in year 4 after surgery and chemotherapy, continuing surveillance scans and living with scan anxiety and lasting treatment effects.

The Patient Story
OutcomeSurvivorship / Completed Treatment